Intensity of Macrophage Infiltration in Glomeruli Predicts Response to Immunosuppressive Therapy in Patients with IgA Nephropathy

Author:

Xie Di,Zhao Hao,Xu XinORCID,Zhou Zhanmei,Su Cailing,Jia Nan,Liu YouhuaORCID,Hou Fan Fan

Abstract

BackgroundThe lack of a tool for predicting the response to immunosuppressive therapy in IgA nephropathy (IgAN) limits patient-specific risk stratification and early treatment decision making. Models for predicting response to immunosuppression in IgAN that can be applied at the time of kidney biopsy are needed.MethodsThis prospective cohort study involved 621 Chinese patients with IgAN who were at high risk for disease progression and had persistent proteinuria ≥1 g/d, despite 3 months of optimized supportive care with renin-angiotensin system inhibitors. Participants received immunosuppressive therapy for a median of 18 months. We used immunochemistry to identify macrophage and lymphocyte infiltrates in biopsy specimens and digital image analysis to quantify them. The outcome was response to immunosuppression, defined as complete or partial remission within 12 months of immunosuppression.ResultsKidney infiltration of CD68+ and CD206+ macrophages increased in patients with IgAN. Having higher levels of glomerular CD206+ macrophage infiltration was associated with a 40-fold increased probability of response to immunosuppression in adjusted analysis compared with having lower levels. Patients with a higher intensity of glomerular CD68+ infiltrates had a 13-fold increase in probability of responding to immunosuppression. Intensity of glomerular CD206+ and CD68+ macrophage infiltration predicted the response to immunosuppression (area under the curve [AUC], 0.84; 95% CI, 0.81 to 0.88). The AUC increased to 0.87 (95% CI, 0.84 to 0.91) in a model combining the infiltration score of CD206+ and CD68+ infiltrates with the MEST-C score and clinical data at biopsy.ConclusionsIntensity of glomerular macrophage infiltration predicted response to immunosuppressive therapy in patients with IgAN who were at high risk of progression, and may help physicians identify patients who will benefit from such treatment.

Funder

Guangzhou Regenerative Medicine and Health Guangdong Laboratory

Guangdong Provincial Key Laboratory of Renal Failure Research

National Innovation Team Program

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference44 articles.

1. IgA Nephropathy

2. A retrospective analysis of the natural history of primary IgA nephropathy worldwide

3. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels

4. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity;Suzuki;J Clin Invest,2009

5. IgA Nephropathy: Molecular Mechanisms of the Disease

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3